The cognitive function and plasma levels of BDNF in patients with type 2 diabetes

ZHOU Hong,CHANG Jinghao,ZHANG Zhijun,TENG Gaojun
DOI: https://doi.org/10.3969/j.issn.1002-0152.2010.05.008
2010-01-01
Abstract:Objective The aims of this study were to investigate the characteristics of cognitive function in patients with type 2 diabetes(DM)and the association of the cognitive function in type 2 DM patients with plasma levels of brain-derived neurotrophic factor(BDNF).Methods Eighty-nine patients with type 2 DM and 40 nondiabetic controls with age and education matched were included in this study.All the subjects received a set of multi-dimension neuropsychologic tests for the cognitive assessment,and the diagnoses of amnesic mild cognitive impairment(aMCI)were made mainly according to the results of cognitive assessment and the criteria of aMCI by Peterson.An enzyme-linked immunosorbent assay(ELISA)was used to measure plasma BDNF concentrations.Results The performances of type 2 DM group in the trial marking test B(TMT B),the delayed recall and recognition of auditory verbal learning test(AVLT-DR&RC),the symbol digit modulation test(SDMT),verbal fluency test(VFT)and clock drawing test(CDT)were obviously worse than those of controls group(P<0.01).Type 2 DM has a strong association with aMCI(OR 95%CI=1.536~10.582,χ2=8.769,P=0.003).In type 2 DM group,patients with aMCI had significantly lower scores of AVLT-DR&RC,VFT,TMT B,CDT,Trial marking test A(TMT A)and delayed recall of Rey-Osterrich complex figure test(CFT-DR),compared to patients without aMCI.The plasma levels of BDNF in type 2 DM group was significantly lower than those in controls group(P<0.01).But there was no correlation between plasma levels of BDNF and scores of each neuropsychological test in type 2 DM group.The plasma levels of BDNF were positively correlation with the scores of DSMT and CFT-DR(r=0.522,P<0.01;r=0.346,P<0.05)only in type 2 DM patients with aMCI.Conclusions Patients with type 2 DM prone to have cognitive impairments and a lower plasma level of BDNF.However,the association between cognitive function in patients with type 2 DM and the levels of BDNF remain to be confirmed.
What problem does this paper attempt to address?